Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma

Tobias Schilling, Astrid Kairat, Gerry Melino, Peter H. Krammer, Wolfgang Stremmel, Moshe Oren, Martina Müller

Research output: Contribution to journalArticle

Abstract

Whereas the hallmark of wild-type p53 is its tumor suppressor activity, tumor-associated mutant p53 proteins can exert novel anti-apoptotic gain-of-function activities, which confer a selective advantage upon tumor cells harboring such mutations. We investigated the molecular mechanisms of mutant p53 gain-of-function in hepatocellular carcinoma with special emphasis on the interaction of mutant p53 gain-of-function proteins with the p53 family members p63 and p73. Mutant forms of p53, namely the hot-spot mutants p53R143A, p53R175D, p53R175H, p53R248W, and p53R273H, acquire anti-apoptotic gain-of-function in hepatocellular carcinoma by repressing the activity of genes regulating both, the extrinsic apoptosis pathway initiated by ligation of death receptors and the intrinsic/mitochondrial apoptosis pathway. In the presence of mutated p53, the CD95L-CD95 apoptotic pathway is markedly attenuated. This is due to repression of CD95 gene transcription by mutant p53. In addition, these mutants repress the expression of the Bax gene and attenuate mitochondria-mediated apoptosis signaling. Furthermore, and of clinical relevance, these gain-of-function mutants are anti-apoptotic due to their inhibitory interaction with the pro-apoptotic p53 family members TAp63 and TAp73. p53 gain-of-function mutants significantly decrease activation of pro-apoptotic target genes by wild-type p53, TAp63, and TAp73. This contributes to the ability of cancer cells to withstand DNA damage-induced apoptosis. Interference with the interaction of p53 gain-of-function mutants with TAp63 or TAp73 may thus sensitize hepatocellular carcinoma to elimination by therapy.

Original languageEnglish
Pages (from-to)817-823
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume394
Issue number3
DOIs
Publication statusPublished - Apr 9 2010

Fingerprint

Hepatocellular Carcinoma
Apoptosis
Genes
Neoplasms
Tumors
Death Domain Receptors
Aptitude
Fas Ligand Protein
p53 Genes
Mutant Proteins
DNA Damage
Ligation
Cells
Mitochondria
Gene Expression
Mutation
Transcription
Proteins
Chemical activation
DNA

Keywords

  • Apoptosis
  • Hepatocellular carcinoma
  • p53
  • p53 gain-of-function
  • p63
  • p73

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma. / Schilling, Tobias; Kairat, Astrid; Melino, Gerry; Krammer, Peter H.; Stremmel, Wolfgang; Oren, Moshe; Müller, Martina.

In: Biochemical and Biophysical Research Communications, Vol. 394, No. 3, 09.04.2010, p. 817-823.

Research output: Contribution to journalArticle

Schilling, Tobias ; Kairat, Astrid ; Melino, Gerry ; Krammer, Peter H. ; Stremmel, Wolfgang ; Oren, Moshe ; Müller, Martina. / Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma. In: Biochemical and Biophysical Research Communications. 2010 ; Vol. 394, No. 3. pp. 817-823.
@article{c9373f202dd64ac584d9e1526d6ea707,
title = "Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma",
abstract = "Whereas the hallmark of wild-type p53 is its tumor suppressor activity, tumor-associated mutant p53 proteins can exert novel anti-apoptotic gain-of-function activities, which confer a selective advantage upon tumor cells harboring such mutations. We investigated the molecular mechanisms of mutant p53 gain-of-function in hepatocellular carcinoma with special emphasis on the interaction of mutant p53 gain-of-function proteins with the p53 family members p63 and p73. Mutant forms of p53, namely the hot-spot mutants p53R143A, p53R175D, p53R175H, p53R248W, and p53R273H, acquire anti-apoptotic gain-of-function in hepatocellular carcinoma by repressing the activity of genes regulating both, the extrinsic apoptosis pathway initiated by ligation of death receptors and the intrinsic/mitochondrial apoptosis pathway. In the presence of mutated p53, the CD95L-CD95 apoptotic pathway is markedly attenuated. This is due to repression of CD95 gene transcription by mutant p53. In addition, these mutants repress the expression of the Bax gene and attenuate mitochondria-mediated apoptosis signaling. Furthermore, and of clinical relevance, these gain-of-function mutants are anti-apoptotic due to their inhibitory interaction with the pro-apoptotic p53 family members TAp63 and TAp73. p53 gain-of-function mutants significantly decrease activation of pro-apoptotic target genes by wild-type p53, TAp63, and TAp73. This contributes to the ability of cancer cells to withstand DNA damage-induced apoptosis. Interference with the interaction of p53 gain-of-function mutants with TAp63 or TAp73 may thus sensitize hepatocellular carcinoma to elimination by therapy.",
keywords = "Apoptosis, Hepatocellular carcinoma, p53, p53 gain-of-function, p63, p73",
author = "Tobias Schilling and Astrid Kairat and Gerry Melino and Krammer, {Peter H.} and Wolfgang Stremmel and Moshe Oren and Martina M{\"u}ller",
year = "2010",
month = "4",
day = "9",
doi = "10.1016/j.bbrc.2010.03.082",
language = "English",
volume = "394",
pages = "817--823",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma

AU - Schilling, Tobias

AU - Kairat, Astrid

AU - Melino, Gerry

AU - Krammer, Peter H.

AU - Stremmel, Wolfgang

AU - Oren, Moshe

AU - Müller, Martina

PY - 2010/4/9

Y1 - 2010/4/9

N2 - Whereas the hallmark of wild-type p53 is its tumor suppressor activity, tumor-associated mutant p53 proteins can exert novel anti-apoptotic gain-of-function activities, which confer a selective advantage upon tumor cells harboring such mutations. We investigated the molecular mechanisms of mutant p53 gain-of-function in hepatocellular carcinoma with special emphasis on the interaction of mutant p53 gain-of-function proteins with the p53 family members p63 and p73. Mutant forms of p53, namely the hot-spot mutants p53R143A, p53R175D, p53R175H, p53R248W, and p53R273H, acquire anti-apoptotic gain-of-function in hepatocellular carcinoma by repressing the activity of genes regulating both, the extrinsic apoptosis pathway initiated by ligation of death receptors and the intrinsic/mitochondrial apoptosis pathway. In the presence of mutated p53, the CD95L-CD95 apoptotic pathway is markedly attenuated. This is due to repression of CD95 gene transcription by mutant p53. In addition, these mutants repress the expression of the Bax gene and attenuate mitochondria-mediated apoptosis signaling. Furthermore, and of clinical relevance, these gain-of-function mutants are anti-apoptotic due to their inhibitory interaction with the pro-apoptotic p53 family members TAp63 and TAp73. p53 gain-of-function mutants significantly decrease activation of pro-apoptotic target genes by wild-type p53, TAp63, and TAp73. This contributes to the ability of cancer cells to withstand DNA damage-induced apoptosis. Interference with the interaction of p53 gain-of-function mutants with TAp63 or TAp73 may thus sensitize hepatocellular carcinoma to elimination by therapy.

AB - Whereas the hallmark of wild-type p53 is its tumor suppressor activity, tumor-associated mutant p53 proteins can exert novel anti-apoptotic gain-of-function activities, which confer a selective advantage upon tumor cells harboring such mutations. We investigated the molecular mechanisms of mutant p53 gain-of-function in hepatocellular carcinoma with special emphasis on the interaction of mutant p53 gain-of-function proteins with the p53 family members p63 and p73. Mutant forms of p53, namely the hot-spot mutants p53R143A, p53R175D, p53R175H, p53R248W, and p53R273H, acquire anti-apoptotic gain-of-function in hepatocellular carcinoma by repressing the activity of genes regulating both, the extrinsic apoptosis pathway initiated by ligation of death receptors and the intrinsic/mitochondrial apoptosis pathway. In the presence of mutated p53, the CD95L-CD95 apoptotic pathway is markedly attenuated. This is due to repression of CD95 gene transcription by mutant p53. In addition, these mutants repress the expression of the Bax gene and attenuate mitochondria-mediated apoptosis signaling. Furthermore, and of clinical relevance, these gain-of-function mutants are anti-apoptotic due to their inhibitory interaction with the pro-apoptotic p53 family members TAp63 and TAp73. p53 gain-of-function mutants significantly decrease activation of pro-apoptotic target genes by wild-type p53, TAp63, and TAp73. This contributes to the ability of cancer cells to withstand DNA damage-induced apoptosis. Interference with the interaction of p53 gain-of-function mutants with TAp63 or TAp73 may thus sensitize hepatocellular carcinoma to elimination by therapy.

KW - Apoptosis

KW - Hepatocellular carcinoma

KW - p53

KW - p53 gain-of-function

KW - p63

KW - p73

UR - http://www.scopus.com/inward/record.url?scp=77950521140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950521140&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2010.03.082

DO - 10.1016/j.bbrc.2010.03.082

M3 - Article

C2 - 20233581

AN - SCOPUS:77950521140

VL - 394

SP - 817

EP - 823

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -